Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSPA8 | P11142 | 5/20 | 0.80 |
| ▸ | HSPA5 | P11021 | 2/20 | 0.80 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.72 |
| ▸ | GAPDH | P04406 | 3/20 | 0.69 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | HBB | P68871 | 1/20 | 0.68 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.64 |
| ▸ | SLC28A2 | O43868 | 4/20 | 0.63 |
| ▸ | DPP4 | P27487 | 1/20 | 0.63 |
| ▸ | MEN1 | O00255 | 1/20 | 0.63 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.63 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.63 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.63 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.63 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.63 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.63 |
| ▸ | STAT6 | P42226 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6305168 | 1.00 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL1145052 | 0.89 | HSPA8 (1.00) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL1145049 | 0.89 | HSPA8 (1.00) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL17412455 | 0.89 | HSPA8 (1.00) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL4126993 | 0.88 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL1135195 | 0.88 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL15906323 | 0.88 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL18858928 | 0.88 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL967124 | 0.88 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 | |
| SCHEMBL15906300 | 0.88 | HSPA8 (0.80) | HSPA8HSPA5RXFP1GAPDHHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180140694-A1 | DOSAGE REGIMEN FOR HIV VACCINE | BIONOR IMMUNO AS (NO) | 2018-05-24 | — | — | US | claimed |
| WO-2016177833-A1 | DOSAGE REGIMEN FOR HIV VACCINE | BIONOR IMMUNO AS (NO) | 2016-11-10 | — | — | WO | claimed |
| US-6900291-B2 | Detection and quantitation of 8-OH-adenine using monoclonal antibodies | CYTOCHEM, INC. (US) | 2005-05-31 | — | — | US | claimed |
| EP-4746905-A1 | RSV VACCINE | Astrazeneca AB (SE) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026104647-A1 | VACCINE | ASTRAZENECA AB (SE) | 2026-05-21 | — | — | WO | disclosed |
| WO-2025125630-A1 | METHOD FOR BIOPROTAC DESIGN | MEDIMMUNE LIMITED (GB) | 2025-06-19 | — | — | WO | disclosed |
| US-20250041400-A1 | RSV VACCINE | ASTRAZENECA PHARMACEUTICALS LP | 2025-02-06 | — | — | US | disclosed |
| WO-2025017142-A1 | RSV VACCINE | ASTRAZENECA AB (SE) | 2025-01-23 | — | — | WO | disclosed |
| WO-2024151994-A1 | MONOCLONAL ANTIBODIES THAT RECOGNIZE 8-OXO-ADENINE IN NUCLEIC ACIDS AND THEIR USE IN DIAGNOSTIC AND QUALITY CONTROL ASSAYS | CYMBA X, LLC (US) | 2024-07-18 | — | — | WO | disclosed |
| US-11976296-B2 | Means and methods for generating midbrain organoids | UNIVERSITÉ DU LUXEMBOURG (LU) | 2024-05-07 | — | — | US | disclosed |
| US-20240009114-A1 | COMPOSITION FOR MICRONEEDLE ADMINISTRATION AND IT'S APPLICATIONS | Zcapsule Pharmaceuticals Co., Ltd. (CN) | 2024-01-11 | — | — | US | disclosed |
| WO-2016177833-A1 | DOSAGE REGIMEN FOR HIV VACCINE | BIONOR IMMUNO AS (NO) | 2016-11-10 | — | — | WO | disclosed |
| WO-2014128289-A1 | BIOMEDICAL DEVICE IMPLANTABLE IN BONE AND/OR CARTILAGINOUS TISSUE, AND CORRESPONDING METHOD TO MANUFACTURE SAID BIOMEDICAL DEVICE | LUMETTI, SIMONE (IT) | 2014-08-28 | — | — | WO | disclosed |
| CN-103502450-A | Methods and materials for nucleic acid manipulation | BASF SE | 2014-01-08 | — | — | CN | disclosed |
| US-20120295311-A1 | Methods and Materials for Nucleic Acid Manipulation | BASF SE (DE) | 2012-11-22 | — | — | US | disclosed |
| US-7244572-B1 | One-dimensional arrays on optical fibers | WISYS TECHNOLOGY FOUNDATION, INC. (US) | 2007-07-17 | — | — | US | disclosed |
| US-6900291-B2 | Detection and quantitation of 8-OH-adenine using monoclonal antibodies | CYTOCHEM, INC. (US) | 2005-05-31 | — | — | US | disclosed |
| US-20030186344-A1 | Detection and quantitation of 8-OH-adenine using monoclonal antibodies | CYTOCHEM, INC. | 2003-10-02 | — | — | US | disclosed |
| US-6187551-B1 | HYBRIDOMA CULTURE PRODUCT | CYTOCHEM, INC. | 2001-02-13 | — | — | US | disclosed |
| WO-1997011371-A1 | DETECTION AND QUANTITATION OF 8-OH-ADENINE USING MONOCLONAL ANTIBODIES | CYTOCHEM, INC. (US) | 1997-03-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250041400-A1 | RSV VACCINE | LSS, SLFN12, FDPS | HSPA8 1320/4885HSPA5 2660/4885RXFP1 2851/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.